Role of Tertiary Lymphoid Structures (TLS) in Anti-Tumor Immunity: Potential Tumor-Induced Cytokines/Chemokines that Regulate TLS Formation in Epithelial-Derived Cancers

Following the successes of monoclonal antibody immunotherapies (trastuzumab (Herceptin(®)) and rituximab (Rituxan(®))) and the first approved cancer vaccine, Provenge(®) (sipuleucel-T), investigations into the immune system and how it can be modified by a tumor has become an exciting and promising n...

Descripción completa

Detalles Bibliográficos
Autores principales: Pimenta, Erica M., Barnes, Betsy J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074812/
https://www.ncbi.nlm.nih.gov/pubmed/24762633
http://dx.doi.org/10.3390/cancers6020969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074812/
https://www.ncbi.nlm.nih.gov/pubmed/24762633
http://dx.doi.org/10.3390/cancers6020969

Ejemplares similares